Inhaled Drug Delivery
- Future needs for inhaled drug delivery
- Innovation in nebulized therapy
- Nebulizers – modern advances
- Development of propellant-free MDIs
- Aerosol-mediated delivery of drugs
- Triple combination inhalers – the challenges
- Functional respiratory imaging
Inhaled drug delivery is also termed as pulmonary drug delivery. It is the inhalation of drug formulation through the mouth and further deposition of the inhaled pharmacological agent in lower airways is the main purpose of this drug delivery rate. The inhalation therapies involved the use of leaves from plants, vapours from aromatic plants, balsams and myhrr. Delivery of drugs directly to the site of action reduces the dose needed to produce a pharmacological effect.
In recent years, the possibility of utilizing the pulmonary route for the systemic delivery of peptides and other molecules that are not absorbed through the gastrointestinal tract has also been explored.
- Future needs for inhaled drug delivery
- Innovation in nebulized therapy
- Nebulizers – modern advances
- Development of propellant-free MDIs
- Aerosol-mediated delivery of drugs
- Triple combination inhalers – the challenges
- Functional respiratory imaging
PDDS 2022 Speakers
Alena Korbut
IHS/Cherokee Nation, United States
Victoria Demina
NEUWAY Pharma GmbH, Germany
Samir Haddouchi
Sotax Pharma Services, France
Miroslav Radenkovic
University of Belgrade, Serbia
Mirjana B. Colovic
University of Belgrade, Serbia
Madhav Bhatia
University of Otago, New ZealandSubmit your abstract Today
Title : Drug Delivery to the Brain using Engineered Protein Capsules (EnPCs®)
Victoria Demina, NEUWAY Pharma GmbH, Germany
Title : Mucoadhesive systems for the fast delivery of drugs
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Hydrogen Sulfide: A Stinky Gas….. and Novel Therapeutic Target for Inflammatory Disease
Madhav Bhatia, University of Otago, New Zealand
Title : Arsenate target specific cell death mechanism in normal and tumoral breast cancer cell lines
Cornelia Braicu, Iuliu Hațieganu University of Medicine and Pharmacy, Romania
Title : Vaccines against rotavirus, data based on a study for safety and efficacy
Merita Kucuku, Freelance consultant, Albania
Title : Cardiac myosin inhibitors – New pharmacological approach for obstructive hypertrophic cardiomyopathy treatment
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Self microemulsifying systems based topical lipstick of antifungal agent
Bhupendra Gopalbhai Prajapati, Ganpat University, India
Title : Development and Evaluation of Structured Strategic Approach for successful accomplishment of Risk-Based Monitoring model from clinical trial inception to completion at clinical trial organization.
Heema Desai, Texila American University, India
Title : Immune checkpoint inhibitors (ICIs) and immune-related adverse drug reactions: Focus on their neurotoxicity
Liberata Sportiello, University of Campania “L. Vanvitelli”, Italy
Title : Latest trends in Bio-degradation of Xenobiotics for cleaning up the environment
Neha Agarwal, University of Lucknow, India